Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers-Reference-Cited by-同舟云学术

Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers

Published:2023-11-21 Issue:1 Volume:201 Page:
ISSN:0033-7587
Container-title:Radiation Research
language:
Short-container-title:Radiation Research

Author:

Fath Melissa A.¹,Liu Dijie²,Ewald Jordan T.¹,Robles-Planells Claudia²,Tomanek-Chalkley Ann M.¹,Graves Stephen A.³,Howe James R.⁴,O'Dorisio Thomas M.⁵,Rastogi Prerna⁶,Bellizzi Andrew M.⁶,O'Dorisio M Sue²,Menda Yusuf³,Spitz Douglas R.¹

Affiliation:

1. Free Radical and Radiation Biology Program, Department of Radiation Oncology

2. Departments of Pediatrics

3. Departments of Radiology

4. Departments of Surgery

5. Departments of Internal Medicine

6. Departments of Pathology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 52240

Publisher

Radiation Research Society

Subject

Radiology, Nuclear Medicine and imaging,Radiation,Biophysics

Link

https://meridian.allenpress.com/radiation-research/article-pdf/doi/10.1667/RADE-23-00064.1/3291853/10.1667_rade-23-00064.1.pdf

Reference42 articles.

1. MH Ullman-Cullere and CJ Foltz "Lab Anim Sci." 49, "Body condition scoring: a rapid and accurate method for assessing health status in mice." 319 (1999)

2. (2019)

3. BH Herzog, S Devarakonda, R Govindan, "J Thorac Oncol." 16, "Overcoming Chemotherapy Resistance in SCLC." 2002 (2021)

4. BG Naraev, RA Ramirez, AT Kendi, et al. "Clin Lung Cancer." 20, "Peptide Receptor Radionuclide Therapy for Patients with Advanced Lung Carcinoids." e376 (2019)

5. T Osl, A Schmidt, M Schwaiger, et al. "Theranostics." 10, "A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency." 8264 (2020)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CXCR4 with [²¹²Pb/²⁰³Pb]-Pentixather Significantly Increases Overall Survival in Small Cell Lung Cancer;2024-09-11

2. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology;The Lancet Oncology;2024-06

3. CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms;Cancers;2024-05-08